FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Provectus Biopharmaceuticals Announces Abstract Available Online of Trials in Progress; Abstract for Poster Presentation at ASCO Annual Meeting
May 19, 2016
Provectus Biopharmaceuticals Announces Publication of Article in Oncotarget Detailing PV-10’s Immuno-Ablative Mechanism of Action
May 13, 2016
Provectus Biopharmaceuticals Will Hold Its 2016 First Quarter Business Update Conference Call on Tuesday, May 10, 2016, at 4 pm Eastern Daylight Time
May 04, 2016
Provectus Biopharmaceuticals Announces Publication of Two Abstracts on Research into IL PV-10 for Melanoma in Special Issue of ANZ Journal of Surgery
April 28, 2016
Provectus Biopharmaceuticals to Participate in Panel at Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact
April 27, 2016
Provectus Biopharmaceuticals Reports Data On PV-10 in Combination Therapy and T Cell Mediated Immunity Presented at American Association for Cancer Research (AACR) Annual Meeting 2016
April 22, 2016
Provectus Biopharmaceuticals Reports Trials in Progress Abstract Accepted for Poster Presentation at ASCO Annual Meeting
April 20, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here